Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:SYK

Stryker Corp. (SYK)

307.00
-0.80 (0.26%)
as of Jun 18, 2026, 8:52:16 pm Market Open.
184 watching
0
COMMENT

A lot of competition for companies like this. Their main job is producing medical devices, such as hips, knees, etc. With the aging population, everybody is going to need these things. This company will do well in expanding into emerging markets. Right now they are basically North American focused. Last quarter came out with some really good numbers, including good cash flow. Not sure he likes the current price. 1.4% dividend yield.

BUY

Great company and doing well. Owns another like it. Zimmer was bought last month. More people are getting health insurance. They both have good drivers.

TOP PICK

Sees opportunities in developing markets and demographics play a good role. Feels their abilities and for similar companies in the medical device area, is to participate with the goal of lowering costs. Companies like this that make the devices, have the opportunity to help lower costs, which will be better for consumers and governments and will ultimately provide better care. Long-term theme.

TOP PICK

Medical devices. Has grown through acquisition. Long track record of dividend growth and have grown 25% over the last 5 years. Trading at around 16X earnings.

BUY
Orthopaedics is an interesting area because of the aging population.
COMMENT
In a demographic sweet spot doing replacement hips, knees etc. Has been doing extremely well over time and expects it will continue to. Would prefer Zimmer (ZMH-N) because of the valuation and the growth rates.
DON'T BUY
Not mispriced. Not their strategy, as they buy mispriced stocks. Doesn't think it's bad, but they wouldn't buy.
DON'T BUY
In the medical device business. They do a lot of orthopaedic devices and equipment for surgical rooms. A lot of the medical device companies have had a slowdown. Seeing some money flowing back into the pharmaceutical industry which is at the detriment of the device companies. Would prefer the generic drug companies.
WATCH
Unbelieable business run by smart guys. Stable business, great stock for long term.
DON'T BUY
Their model price is $27. Too expensive. A quality name.
WEAK BUY
Trades at high P/E multiples. A high quality company.
Showing 136 to 146 of 146 entries